NIH PAR · NCI · R03
PAR-25-233: Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance…
- NOFO number
- PAR-25-233
- Type
- PAR
- Activity code
- R03
- Primary institute
- NCI · National Cancer Institute
- Clinical trials
- Not Allowed
- Posted
- Oct 30, 2024
- Opens
- Jan 16, 2025
- Expires
- Jan 8, 2028
PAR-25-233 due dates
4 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 16, 2025 | March 16, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 16, 2025 | July 16, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 16, 2025 | November 16, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 16, 2026 | March 16, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 16, 2026 | July 16, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 16, 2026 | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 16, 2027 | March 16, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 16, 2027 | July 16, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 16, 2027 | November 16, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
What its predecessor PAR-22-106 funded
PAR-25-233 reissues PAR-22-106. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 3 projects and $517K in FY2022–FY2026.
Projects funded
3
Distinct projects, FY2022–FY2026
New awards
3
Type 1 (new project) award records
NIH funding
$517K
Award dollars under PAR-22-106, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 1 | 1 | $89K |
| FY2024 | 3 | 2 | $340K |
| FY2025 | 1 | 0 | $88K |
| FY2026 | 0 | 0 | $0 |
Institutions with the most funding
- Brown University$191K · 1 project
- Boston Medical Center$178K · 1 project
- University of North Texas Hlth Sci Ctr$148K · 1 project
Funding institutes
- NIDA$369K · 4
- NICHD$148K · 1
Activity codes funded
- R035 records
Most recent new awards
- Multilevel determinants of prenatal syphilis screening policy implementation (opens NIH RePORTER)
University of North Texas Hlth Sci Ctr · 1R03HD113901-01 · NICHD · Notice Aug 13, 2024
$148KR03
- Towards a harm reduction approach to perinatal cannabis use (opens NIH RePORTER)
Brown University · 1R03DA059668-01A1 · NIDA · Notice Jul 12, 2024
$103KR03
- Community-engaged implementation strategies for acceptance interventions to improve access to care for people with HIV and injection drug use (opens NIH RePORTER)
Boston Medical Center · 1R03DA059341-01 · NIDA · Notice Aug 21, 2023
$89KR03
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
14 NIH institutes and offices take applications under PAR-25-233. Contact the program officer at the institute that fits your research before applying.
- NCI · National Cancer Institute
- NHGRI · National Human Genome Research Institute
- NIA · National Institute on Aging
- NIAAA · National Institute on Alcohol Abuse and Alcoholism
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIDCR · National Institute of Dental and Craniofacial Research
- NIDA · National Institute on Drug Abuse
- NIEHS · National Institute of Environmental Health Sciences
- NIMH · National Institute of Mental Health
- NINDS · National Institute of Neurological Disorders and Stroke
- FIC · Fogarty International Center
- THRO
- ODP
- OBSSR
Related notices
Jan 28, 2026 · NOT-OD-26-029
NIH Removing AIDS Application Due Dates from NOFOs. See Notice NOT-OD-26-029.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025.
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Notices of Special Interest (NOSIs)
NIH has attached 10 NOSIs to PAR-25-233; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewResubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- A budget for direct costs of up to 50,000 per year may be requested.
- Project period
- The maximum project period is 2 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-22-106.
- Companion NOFOs: PAR-25-144.
Other open NOFOs for R03
- PAR-25-370Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NHGRI · next due Oct 16, 2026
- PA-25-302NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)NIH · next due Oct 16, 2026
- PAS-27-028Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)NIDA · next due Oct 16, 2026
- PAR-27-074Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)NIAMS · next due Oct 16, 2026
- PAR-25-091Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)NIDDK · next due Oct 16, 2026
- PA-25-125NICHD Small Research Grant Program (R03 Clinical Trial Required)NICHD · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.